stockrow
Friday 6 November 2026
Export NEPH’s income statement to Excel — free account
Nephros Inc.
NEPH Healthcare Medical Instruments & Supplies
Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024.
- Revenue
- +18.0%
- EPS
- +66.7%
- Free cash flow
- −251.5%
Quarter to September 2026, against a year earlier
2.82
0.27
−8.74%
Follow NEPH
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 6 | 2 | 6 | 1 | 3 | 4 | 6 | 5 | 7 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.12 |
Altman Z-Score |
(60.08) | (29.56) | (10.63) | (3.30) | 6.54 | 2.19 | (14.45) | (9.50) | (12.50) | (3.26) |
P/S ratio |
8.79 | 6.25 | 6.18 | 7.26 | 9.10 | 5.79 | 1.15 | 2.50 | 1.09 | 2.76 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54.89 | 0.00 | 34.07 |
Altman Z″-Score (non-manufacturers) |
(152.37) | (79.01) | (34.93) | (32.16) | (14.31) | (16.79) | (36.49) | (34.61) | (34.59) | (26.46) |
Beneish M-Score |
(4.43) | (2.49) | (1.61) | (2.44) | (1.44) | (2.61) | (2.99) | (3.32) | (2.01) | (2.60) |
P/Operating CF |
(38.64) | 13.28 | (66.52) | 206.16 | (51.05) | (176.44) | (58.61) | (150.31) | 11.86 | 225.16 |
P/B ratio |
30.59 | 12.21 | 5.17 | 9.76 | 5.00 | 4.01 | 1.29 | 4.26 | 1.80 | 5.08 |
Price to Tangible BV |
0.00 | 27.13 | 7.77 | 13.45 | 5.71 | 4.55 | 1.57 | 5.13 | 2.13 | 5.78 |
EV/Sales |
9.03 | 6.11 | 5.69 | 6.97 | 8.30 | 5.11 | 0.78 | 2.20 | 0.83 | 2.47 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.94 | 36.10 |
EV/Operating CF |
(9.91) | (302.21) | (8.84) | (31.66) | (10.29) | (36.86) | (2.41) | 37.88 | (23.82) | 28.20 |
EV/FCF |
(9.71) | (190.74) | (8.73) | (31.39) | (9.95) | (35.95) | (2.31) | 48.26 | (18.99) | 30.52 |
Quick Ratio |
0.77 | 1.63 | 2.24 | 2.15 | 7.26 | 3.60 | 3.48 | 2.75 | 3.55 | 2.82 |
Current Ratio |
1.41 | 2.04 | 3.08 | 3.42 | 11.44 | 5.70 | 5.85 | 3.98 | 5.31 | 4.06 |
Net Debt/EBITDA |
(0.21) | 0.29 | 0.97 | 1.01 | 1.82 | 2.29 | 0.91 | 3.12 | (26.29) | (4.20) |
Debt/Assets |
31.29% | 33.41% | 17.37% | 10.09% | 4.57% | 0.56% | 0.01% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.26 | 0.85 | 0.27 | 0.15 | 0.05 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.70 | 0.99 | 0.73 | 0.93 | 0.57 | 0.57 | 0.70 | 1.25 | 1.23 | 1.51 |
Operating CF/Net income |
0.70 | 0.10 | 1.08 | 0.67 | 1.45 | 0.35 | 0.44 | (0.53) | (6.65) | 1.38 |
Capex/Depreciation |
(0.16) | 0.00 | 0.00 | (0.07) | (1.15) | (0.14) | (0.39) | (0.35) | (0.36) | 0.00 |
Interest Coverage |
(16.68) | (7.37) | (17.53) | (16.18) | (38.86) | (79.32) | (216.75) | (796.50) | 6.00 | 1,146.00 |
| (182.05%) | (61.83%) | (77.78%) | (47.21%) | (40.98%) | (27.09%) | (62.48%) | (18.27%) | 0.87% | 12.71% | |
| (91.22%) | (21.12%) | (43.78%) | (30.83%) | (31.63%) | (22.72%) | (51.53%) | (13.78%) | 0.64% | 9.61% | |
ROIC |
(149.05%) | (99.30%) | (46.53%) | (41.99%) | (32.70%) | (25.81%) | (51.63%) | (24.58%) | 0.08% | 14.92% |
Return on Tangible Assets |
(690.66%) | (40.65%) | (60.64%) | (57.46%) | (33.74%) | (36.29%) | (105.99%) | (24.44%) | 1.07% | 13.95% |
Average Days of Receivables |
61.04 | 80.11 | 87.22 | 36.91 | 58.15 | 58.62 | 47.06 | 38.35 | 45.90 | 46.90 |
Research and Development Expense of Revenue |
46.51% | 26.31% | 27.06% | 29.90% | 32.23% | 14.66% | 12.58% | 6.13% | 6.40% | 7.13% |
Selling, General and Administrative Expense of Revenue |
123.02% | 86.58% | 79.43% | 59.21% | 75.53% | 70.42% | 76.12% | 62.59% | 54.20% | 47.90% |
Intangible Assets out of Total Assets |
0.47 | 0.22 | 0.22 | 0.18 | 0.10 | 0.10 | 0.14 | 0.12 | 0.12 | 0.09 |
Share Based Compensation of Revenue |
25.73% | 20.27% | 17.32% | 12.89% | 9.10% | 12.32% | 9.84% | 7.39% | 1.08% | 1.58% |
Graham Net Nets |
(0.04) | 0.03 | 0.13 | 0.06 | 0.16 | 0.18 | 0.54 | 0.14 | 0.37 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 |
Earnings Yield |
(16.16%) | (4.08%) | (10.53%) | (4.42%) | (6.06%) | (6.95%) | (64.05%) | (4.37%) | 0.00% | 2.17% |
Free Cash Flow Yield |
(10.57%) | (0.51%) | (10.55%) | (3.06%) | (9.17%) | (2.46%) | (29.49%) | 1.82% | (3.99%) | 2.94% |
Revenue per Share |
0.43 | 0.65 | 0.83 | 1.37 | 0.94 | 1.02 | 0.97 | 1.37 | 1.35 | 1.77 |
Operating CF per Share |
(0.39) | (0.01) | (0.53) | (0.30) | (0.76) | (0.14) | (0.31) | 0.08 | (0.05) | 0.16 |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | (0.03) | 0.00 | (0.01) | (0.01) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.40) | (0.01) | (0.53) | (0.30) | (0.79) | (0.14) | (0.33) | 0.07 | (0.05) | 0.16 |
Cash per Share |
0.06 | 0.38 | 0.67 | 0.55 | 0.91 | 0.70 | 0.35 | 0.41 | 0.36 | 0.51 |
Shareholders Equity per Share |
0.12 | 0.33 | 0.99 | 1.02 | 1.72 | 1.47 | 0.86 | 0.80 | 0.82 | 0.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.12 | 0.33 | 0.99 | 1.02 | 1.72 | 1.47 | 0.86 | 0.80 | 0.82 | 0.96 |
Free Cash Flow |
(2.16) | (0.08) | (3.66) | (2.29) | (7.14) | (1.45) | (3.37) | 0.75 | (0.54) | 1.65 |
Working Capital |
0.37 | 1.94 | 5.52 | 5.87 | 13.83 | 11.24 | 6.85 | 6.29 | 6.74 | 8.46 |
Capital Expenditures |
(0.04) | — | — | (0.01) | (0.24) | (0.04) | (0.14) | (0.07) | (0.05) | — |
Net Current Asset Value |
(0.75) | 0.78 | 4.41 | 4.36 | 12.22 | 10.73 | 6.14 | 4.90 | 5.67 | 7.78 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,952.96 | 40.48 |
Capex to Sales |
0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,578.63 | 45.19 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
4.04 | 6.42 | 2.16 | 2.47 | 0.71 | 3.50 | 3.03 | 1.41 | 0.85 | 1.31 |
Cash ROIC |
(119.37%) | (1.32%) | (27.72%) | (17.58%) | (28.95%) | (6.66%) | (26.93%) | 5.94% | (4.39%) | 10.54% |
Accounts Receivable Turnover |
5.91 | 6.22 | 5.18 | 8.60 | 7.11 | 6.80 | 6.82 | 10.24 | 8.64 | 8.96 |
Accounts Payable Turnover |
1.66 | 2.08 | 2.91 | 4.74 | 5.28 | 5.22 | 5.06 | 7.23 | 7.15 | 9.17 |
Inventory Turnover |
1.92 | 2.63 | 1.96 | 1.92 | 0.93 | 0.94 | 1.38 | 2.07 | 2.14 | 2.45 |
Average Days of Payables |
208.11 | 209.81 | 122.84 | 82.36 | 42.32 | 106.22 | 51.51 | 54.63 | 43.55 | 46.57 |
Days of Inventory on Hand |
170.40 | 162.17 | 273.90 | 220.03 | 530.69 | 355.29 | 219.46 | 154.56 | 175.49 | 164.67 |
Average Receivables |
0.39 | 0.61 | 1.10 | 1.20 | 1.20 | 1.50 | 1.46 | 1.39 | 1.64 | 2.10 |
Average Payables |
0.62 | 0.73 | 0.85 | 0.90 | 0.69 | 0.88 | 1.04 | 0.81 | 0.76 | 0.78 |
Average Inventory |
0.54 | 0.58 | 1.27 | 2.21 | 3.93 | 4.88 | 3.81 | 2.81 | 2.54 | 2.92 |
Average Assets |
3.32 | 3.83 | 7.77 | 11.09 | 15.07 | 18.08 | 14.32 | 11.43 | 11.54 | 12.43 |
Average Common Equity |
1.67 | 1.31 | 4.37 | 7.24 | 11.63 | 15.16 | 11.82 | 8.62 | 8.47 | 9.39 |
Columns are period end dates · fundamentals updated 5 Nov 2026